Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (101-110 of 272) with videos related to

Pageof 28
Sort By:
Cancer Letters|June 28, 2005
Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignanciesUta Schmidt, Susanne Fuessel, Michael Haase, et al.
Urologia Internationalis|March 15, 2013
Perioperative complications after radical prostatectomy: open versus robot-assisted laparoscopic approachMichael Froehner, Vladimir Novotny, Rainer Koch, et al.
Urologia Internationalis|January 21, 2016
Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder CancerVladimir Novotny, Michael Froehner, Johanna Ollig, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 26, 2004
Gastrointestinal stromal tumor presenting as a scrotal massMichael Froehner, Detlef Ockert, Daniela E Aust, et al.
Cancer Investigation|January 19, 2013
Immunohistochemical analysis of prognostic protein markers for primary localized clear cell renal cell carcinomaThomas Weber, Matthias Meinhardt, Stefan Zastrow, et al.
International Journal of Oncology|July 17, 2012
Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cellsDoreen Kunze, Kai Kraemer, Kati Erdmann, et al.
Urologia Internationalis|January 31, 2019
In-Hospital Outcomes after Radical Cystectomy for Bladder Cancer: Comparing National Trends in the United States and Germany from 2006 to 2014Christer Groeben, Rainer Koch, Martin Baunacke, et al.
Clinical Therapeutics|May 10, 2005
The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal usePierre Teillac, Aldo V Bono, Jacques Irani, et al.
Urology|October 11, 2003
Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomyMichael Froehner, Rainer Koch, Rainer Litz, et al.
BJU International|November 3, 2011
Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?Michael Froehner, Rainer Koch, Rainer J Litz, et al.
Pageof 28

Showing results (101-110 of 272) with videos related to

Sort By:
Pageof 28
Cancer Letters|June 28, 2005
Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignanciesUta Schmidt, Susanne Fuessel, Michael Haase, et al.
Urologia Internationalis|March 15, 2013
Perioperative complications after radical prostatectomy: open versus robot-assisted laparoscopic approachMichael Froehner, Vladimir Novotny, Rainer Koch, et al.
Urologia Internationalis|January 21, 2016
Impact of Adjuvant Intravesical Bacillus Calmette-Guérin Treatment on Patients with High-Grade T1 Bladder CancerVladimir Novotny, Michael Froehner, Johanna Ollig, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 26, 2004
Gastrointestinal stromal tumor presenting as a scrotal massMichael Froehner, Detlef Ockert, Daniela E Aust, et al.
Cancer Investigation|January 19, 2013
Immunohistochemical analysis of prognostic protein markers for primary localized clear cell renal cell carcinomaThomas Weber, Matthias Meinhardt, Stefan Zastrow, et al.
International Journal of Oncology|July 17, 2012
Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cellsDoreen Kunze, Kai Kraemer, Kati Erdmann, et al.
Urologia Internationalis|January 31, 2019
In-Hospital Outcomes after Radical Cystectomy for Bladder Cancer: Comparing National Trends in the United States and Germany from 2006 to 2014Christer Groeben, Rainer Koch, Martin Baunacke, et al.
Clinical Therapeutics|May 10, 2005
The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal usePierre Teillac, Aldo V Bono, Jacques Irani, et al.
Urology|October 11, 2003
Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomyMichael Froehner, Rainer Koch, Rainer Litz, et al.
BJU International|November 3, 2011
Which patients are at the highest risk of dying from competing causes ≤ 10 years after radical prostatectomy?Michael Froehner, Rainer Koch, Rainer J Litz, et al.
Pageof 28